ReviewAmerican journal of clinical and experimental immunology2026
Antagonists of platelet-derived growth factors (PDGFs) and their receptors (PDGFRs) as rationale and therapeutic potential of combination cancer therapy.
Hai Qian et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.